Evidence map›Paper›PMID 34832156›Full record

ReviewMaterials (Basel, Switzerland)2021

2,7(3,6)-Diaryl(arylamino)-substituted Carbazoles as Components of OLEDs: A Review of the Last Decade.

Gintare Krucaite, Saulius Grigalevicius

Abstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Analysis on the Mechanical Behavior of Flexible Screens.Materials (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Gintare KrucaiteDepartment of Polymers Chemistry and Technology, Kaunas University of Technology, Radvilenu Plentas 19, LT50254 Kaunas, Lithuania.
Saulius GrigaleviciusDepartment of Polymers Chemistry and Technology, Kaunas University of Technology, Radvilenu Plentas 19, LT50254 Kaunas, Lithuania.ORCID 0000-0002-3346-7585

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organic light emitting diode (OLED) is a new, promising technology in the field of lighting and display applications due to the advantages offered by its organic electroactive derivatives over inorganic materials. OLEDs have prompted a great deal of investigations within academia as well as in industry because of their potential applications. The electroactive layers of OLEDs can be fabricated from low molecular weight derivatives by vapor deposition or from polymers by spin coating from their solution. Among the low-molar-mass compounds under investigation in this field, carbazole-based materials have been studied at length for their useful chemical and electronic characteristics. The carbazole is an electron-rich heterocyclic compound, whose structure can be easily modified by rather simple reactions in order to obtain 2,7(3,6)-diaryl(arylamino)-substituted carbazoles. The substituted derivatives are widely used for the formation of OLEDs due to their good charge carrier injection and transfer characteristics, electroluminescence, thermally activated delayed fluorescence, improved thermal and morphological stability as well as their thin film forming characteristics. On the other hand, relatively high triplet energies of some substituted carbazole-based compounds make them useful components as host materials even for wide bandgap triplet emitters. The present review focuses on 2,7(3,6)-diaryl(arylamino)-substituted carbazoles, which were described in the last decade and were applied as charge-transporting layers, fluorescent and phosphorescent emitters as well as host materials for OLED devices.

Indexed as

amorphous materialcharge transporting layeremitterhost materialorganic light emitting diodesubstituted carbazole

Identifiers

PMID34832156
PMCPMC8620482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.